Unique Advantages

Innovative Force, Deep Experience

Crossix, the innovative force in consumer Rx analytics and newest entrant to Rx consumer marketing analytics has a fundamentally different technology and approach specifically designed for consumer/patient analytics, allowing optimization, not just rear-mirror measurement.

As a leader in Rx-based consumer marketing analytics, Crossix brings deep experience to its clients, having worked with many of the largest pharmaceutical companies and brands, media agencies, publishers and other media companies, covering a broad range of conditions and indications.

Broadly Applicable

Crossix offers solutions to measure and optimize programs ranging from direct response (DR) to general awareness and branding campaigns (GA), and multi channel, from Web to Print to TV.

For any identifiable audiences, Crossix is wired to inform, providing answers to key marketing questions – reaching the right audience? Converting net of control? Staying on therapy? Crossix partnerships help identify the relevant audiences and allow measurement of the full range of marketing possibilities, including lead ratings, co-pay card providers, doctors' office registration, online and offline publishers, internet panels, TV viewers, etc. Crossix continues to add Publisher and Media Measurement Partners, sometimes driven by specific pharma client requests, as well as independently.

Standardized across brands by major pharma companies, media agencies and online and offline publishers, Crossix has replaced retrofitted Rx analytics solutions from traditional (physician-focused) analytics companies.

Better Technology

All other Rx analytics providers have one thing in common – data assets and processes designed for another purpose, now ineffectively applied to consumer marketing applications, with serious and fundamental drawbacks that call into question their usability and reliability.

Crossix has specifically replaced existing analytics vendors, after rigorous and thorough head to head benchmark testing by pharma market research groups of Crossix vs. prior analyses done by other analytics companies.

Crossix simply has a better, faster, more cost effective approach to consumer/patient matchback.

Breakthrough Innovation

It's not the data that makes the difference – Crossix has a revolutionary, patented methodology and technology designed for consumer marketing to radically enhance the accuracy and timeliness of results, leading to a range of entirely new applications for the data. Combined with world class analytics, and Crossix pharma clients move beyond measurement to optimization and demonstrably more effective campaigns.

Capitalizing on this inherent technological advantage, Crossix does not stand still, continually innovating, with additional analytics and applications, new partnerships and access to data all aimed at improved healthcare outcomes through enhanced communications with patients and consumers.

Crossix empowers our clients to reach the right audience, at the right time, with the right message ... cost effectively.

Uniquely-effective Rx-driven Analytics

Crossix ScoreBoard™ Reports link groups of individuals targeted by or exposed to DTC/P campaigns with actual Rx-based prescription behavior, allowing for optimization of marketing spend. Crossix RxMarketMetrics™ provides market benchmarks for performance of patient and consumer marketing activities based on the breadth of actual Crossix ScoreBoard™ and other Rx analyses completed.

The patented, privacy-safe technology and methodology provides significant and unique advantages in the marketplace.

  • Accurate and Authenticated
  • Reliably match based on varying amounts of patient information
  • Allow for household structures - consumer marketing often includes, and in some categories focuses on, caregivers
  • Timely and Repeatable
  • Close to real-time results, with monthly comparison updates
  • Waiting months for results means planning based on unreliable data and precludes real-time optimization
  • Actionable
  • Translate regularly updated metrics to dollars
  • Compare the effectiveness of campaigns and optimize the portfolio of DTC/P spending

Crossix designed its patented data utilization and analytics methodology specifically for consumer/patient analytics – the only matchback company to do so. Crossix sends client lists grouped by media source or segment to its network of data suppliers. Crossix SafeMine™ installations, behind the firewall at each data supplier in the data network, match client or other input lists against to up-to-date pharmacy transactions, using sophisticated matching technology. This results in very high-quality matching and allows for analytics at a household level – critical for consumer marketing analytics. Crossix receives de-identified transactions from each SafeMine installation and combines the results across all data suppliers in the aggregated analyses.

Crossix has specifically replaced existing analytics vendors at several large pharma companies, after rigorous and thorough head to head benchmark testing of Crossix vs. prior analyses done by others. Crossix simply has a better, faster, more cost effective approach to consumer/patient matchback.

Crossix analytical process specifically complies with privacy laws and regulations, including HIPAA; in fact, it's a state-of-the-art process, not only in terms of providing better results, but also in terms of a principled respect for privacy, by design.

Learn more about the Crossix ScoreBoard™ Reports, or if you are interested in more information, contact us.